CJC-1295 / Ipamorelin — Research Use Only

Description

CJC-1295 / Ipamorelin is a synergistic combination of two distinct synthetic peptides designed for laboratory investigation. CJC-1295 is a 29-amino acid tetrasubstituted peptide analog of Growth Hormone Releasing Hormone ($Tyr$–$D$–$Ala$–$Asp$–$Ala$–$Ile$–$Phe$–$Thr$–$Gln$–$Ser$–$Tyr$–$Arg$–$Lys$–$Val$–$Leu$–$Ala$–$Gln$–$Leu$–$Ser$–$Ala$–$Arg$–$Lys$–$Leu$–$Leu$–$Gln$–$Asp$–$Ile$–$Ile$–$Ser$–$Arg$–$NH_2$), while Ipamorelin is a pentapeptide ghrelin mimetic ($Aib$–$His$–$D$–$2$–$Nal$–$D$–$Phe$–$Lys$–$NH_2$). This compound blend is provided as a high-purity chemical reagent intended for in-vitro laboratory research into endocrine signaling and pituitary somatotroph regulation. Research applications focus on the study of GHRH-receptor agonism and GHS-R1a (ghrelin receptor) pathways in response to metabolic and growth signaling stress models.

Research Use Only – Legal Disclaimer

This product is sold strictly for in vitro laboratory research and educational purposes only. It is not for human or animal use, including use in dogs, pets, or livestock, and must not be used for diagnostic, therapeutic, medical, veterinary, or household purposes.

This compound has not been evaluated or approved by the U.S. Food and Drug Administration (FDA) and is not intended to diagnose, treat, cure, or prevent any disease.

By purchasing from Nexus Compounds, the purchaser represents and warrants that they are a qualified professional acquiring this product solely for lawful research purposes. The purchaser assumes all responsibility for proper handling, storage, and use, and for compliance with all applicable federal, state, and local laws. Nexus Compounds disclaims all liability for misuse, improper application, or unauthorized use of this product.